
Georgios Deftereos MD
Cytopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology
Physician
Join to View Full Profile
1825 4th StSan Francisco, CA 94143
Phone+1 415-353-7043
Fax+1 415-353-7676
Are you Dr. Deftereos?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Georgios Deftereos, MD is a board certified pathologist in San Francisco, California. He is currently licensed to practice medicine in California, Texas, and Colorado.
Education & Training
- Allegheny Health Network Medical Education Consortium (AGH)Residency, Pathology-Anatomic and Clinical, 2010 - 2014
- University of Bari Faculty of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2022 - 2026
- TX State Medical License 2018 - 2024
- UT State Medical License 2016 - 2024
- CO State Medical License 2017 - 2023
- PA State Medical License 2010 - 2022
- PA State Medical License 2013 - 2022
- WA State Medical License 2014 - 2022
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
- American Board of Pathology Pathology - Molecular Genetic
- Join now to see all
Publications & Presentations
PubMed
- Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ Hybridization.Cameron Beech, Diane M Wilcock, Kristina H Moore, Leslie Rowe, Jonathan Mahlow
Applied Immunohistochemistry & Molecular Morphology. 2025-03-01 - 2 citationsA Pipeline for Evaluation of Machine Learning/Artificial Intelligence Models to Quantify Programmed Death Ligand 1 Immunohistochemistry.Beatrice S Knudsen, Alok Jadhav, Lindsey J Perry, Jeppe Thagaard, Georgios Deftereos
Laboratory Investigation; a Journal of Technical Methods and Pathology. 2024-06-01 - 2 citationsQuantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast Cancer.Diane M Wilcock, Kristina H Moore, Leslie Rowe, Jonathan Mahlow, Jolanta Jedrzkiewicz
Archives of Pathology & Laboratory Medicine. 2023-12-01